Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patients with medication-refractory OAB symptoms should be further treated with neuromodulation.

Literature DB >> 21801688

Patients with medication-refractory OAB symptoms should be further treated with neuromodulation.

Jerzy B Gajewski¹.

Abstract

Entities: Disease Species

Year: 2011 PMID： 21801688 PMCID： PMC3147045 DOI： 10.5489/cuaj.11039

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

× No keyword cloud information.

15 in total

1. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696

2. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors: Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal: Eur Urol Date: 2006-10-02 Impact factor: 20.096

3. Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder.

Authors: Randall K Leong; Stephan G G de Wachter; Manuela A Joore; Philip E V van Kerrebroeck
Journal: BJU Int Date: 2010-12-16 Impact factor: 5.588

4. Satisfaction and patient experience with sacral neuromodulation: results of a single center sample survey.

Authors: Randall K Leong; Tom A Marcelissen; Fred H Nieman; Rob A De Bie; Philip E Van Kerrebroeck; Stefan G De Wachter
Journal: J Urol Date: 2010-12-18 Impact factor: 7.450

5. Neuromodulation versus medication for overactive bladder: the case for early intervention.

Authors: Frank N Burks; Kenneth M Peters
Journal: Curr Urol Rep Date: 2009-09 Impact factor: 3.092

6. Refractory idiopathic urge urinary incontinence and botulinum A injection.

Authors: Linda Brubaker; Holly E Richter; Anthony Visco; Sangeeta Mahajan; Ingrid Nygaard; Thomas M Braun; Matthew D Barber; Shawn Menefee; Joseph Schaffer; Anne M Weber; John Wei
Journal: J Urol Date: 2008-05-21 Impact factor: 7.450

Review 7. A review of adherence to drug therapy in patients with overactive bladder.

Authors: Ramandeep K Basra; Adrian Wagg; Christopher Chapple; Linda Cardozo; David Castro-Diaz; Montserrat Espuna Pons; Mike Kirby; Ian Milsom; Mark Vierhout; Philip Van Kerrebroeck; Con Kelleher
Journal: BJU Int Date: 2008-07-04 Impact factor: 5.588

8. Prevalence and burden of overactive bladder in the United States.

Authors: W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal: World J Urol Date: 2002-11-15 Impact factor: 4.226

Review 9. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review.

Authors: Miriam Brazzelli; Alison Murray; Cynthia Fraser
Journal: J Urol Date: 2006-03 Impact factor: 7.450

10. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.

Authors: Arun Sahai; Mohammad Shamim Khan; Prokar Dasgupta
Journal: J Urol Date: 2007-06 Impact factor: 7.450

3 in total